However, it is reasonable, that in the absence of Tregs, CD4+ T cells might activate tumor-resident DCs through CD40L–CD40 interaction, which then can efficiently present tumor antigen and promote T cell activation (74, 75). This evidence concerns the gene CD4 and neoplasm.